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X-ray crystallographyNaproxen esterase (NP) from Bacillus subtilis Thai I-8 is a carboxylesterase that catalyzes the enantioselective hy-
drolysis of naproxenmethylester to produce S-naproxen (E N 200). It is a homolog of CesA (98% sequence iden-
tity) and CesB (64% identity), both produced by B. subtilis strain 168. CesB can be used for the enantioselective
hydrolysis of 1,2-O-isopropylideneglycerol (solketal) esters (E N 200 for IPG-caprylate). Crystal structures of
NP and CesB, determined to a resolution of 1.75 Å and 2.04 Å, respectively, showed that both proteins have a ca-
nonical α/β hydrolase fold with an extra N-terminal helix stabilizing the cap subdomain. The active site in both
enzymes is located in a deep hydrophobic groove and includes the catalytic triad residues Ser130, His274, and
Glu245. A product analog, presumably 2-(2-hydroxyethoxy)acetic acid, was bound in the NP active site. The en-
zymes have different enantioselectivities, which previously were shown to result from only a few amino acid
substitutions in the cap domain. Modeling of a substrate in the active site of NP allowed explaining the different
enantioselectivities. In addition, Ala156 may be a determinant of enantioselectivity as well, since its side chain
appears to interfere with the binding of certain R-enantiomers in the active site of NP. However, the exchange
route for substrate and product between the active site and the solvent is not obvious from the structures.
Flexibility of the cap domain might facilitate such exchange. Interestingly, both carboxylesterases show higher
structural similarity to meta-cleavage compound (MCP) hydrolases than to other α/β hydrolase fold esterases.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Nature has evolved a diverse range of esterases with high regio- and
stereoselectivity to convert a broad variety of chemical compounds in
variousmetabolic processes [1]. Because of their speciﬁcity and selectiv-
ity, they are frequently used in biotechnological applications, such as in
the food industry, for the production of perfumes, and for the synthesis
of pharmaceuticals [2].
Carboxylesterases (carboxylic acid ester hydrolases, E.C. 3.1.1.1.) are a
subset of esterases that hydrolyze small, water-soluble ester containing
molecules resulting in the formation of an alcohol and a carboxylic acid.
The microorganism B. subtilis strain Thai I-8 produces an enantiospeciﬁc
carboxylesterase, called naproxen esterase or carboxylesterase NP (NP),
which can be applied as a biocatalyst for the enantioselective resolu-
tion of racemic 2-arylpropionates, such as the important non-steroidalarboxylesterase CesA; CesB,
, 1,2-O-isopropylideneglycerol;
ll Biology, University of Aveiro,
loria 26,University of Milano,
ights reserved.anti-inﬂammatory drugs naproxen, ibuprofen, indomethacin, and
nabumetone. NP has a product ee of 96% based on the substrate
S-naproxenmethylester (Fig. 1) and 99% on S-naproxenethylester
(E N 200) [3,4]. In contrast, the enzyme's enantioselectivity towards
1,2-O-isopropylideneglycerol esters (IPG esters) (Fig. 1) is not sufﬁcient
for industrial processes (E values of ~1.2 for C4 and 1.3 for C8 IPG esters,
respectively) [5]. (S)-IPG (D-(+)-solketal) is an important building
block for the synthesis of the biologically active forms of several
well-known pharmaceuticals and endogenous compounds such as
β-blockers, prostaglandins, and leukotrienes [5,6].
B. subtilis strain 168 contains two homologs of NP called CesA (98%
identical to NP; also known as carboxylesterase NA) and CesB (64%
identical to NP; also known as YbfK). Unlike NP, CesB does convert
(S)-IPG-caprylate ester with high enantioselectivity to (S)-IPG (ee of
99.9%, E N 200), but not (R)-IPG-caprylate ester (Fig. 1) [5]. No marked
differences in activity and selectivity were observed between NP and
CesA [7].
All carboxylesterases of which 3D-structures have been elucidated
to date share high structural similarity; all contain the characteristic
α/β hydrolase fold (see the ESTHER database) [8]. This fold is composed
of a central β-sheet ﬂanked on both sides by α-helices and serves as a
stable protein core where, during evolution, amino acid substitutions,
loop insertions or deletions have led to enzymes with diverse catalytic
functions [9–13].
Fig. 1. Two-dimensional depiction of the reaction catalyzed by the carboxylesterases. The * indicates the chiral carbon atom.
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alytic triad with a sequence order of nucleophile, acid, and histidine
[14]. In carboxylesterases the nucleophile is a serine residue, while the
acid can be an aspartate or a glutamate residue. The serine residue is
the central residue of the conserved pentapeptide sequence motif
Gly–X1–Ser–X2–Gly [1], which deﬁnes a ‘nucleophilic elbow’ character-
ized by a very sharp turn between strand β5 and the followingα-helix.
In the discussed carboxylesterases this motif is Gly–Leu–Ser–Leu–Gly.
The catalytic mechanism proposed for carboxylesterases starts with
nucleophilic attack by the serine hydroxyl group on the substrate car-
bonyl carbon atom of the scissile bond. The serine hydroxyl group is ac-
tivated by the catalytic histidine/acid pair, which takes up the proton
from the Ser OH group. A transient tetrahedral intermediate is formed,
which is stabilized by two peptide nitrogen atoms, usually from resi-
dues on strands β5 and β3, forming the so-called “oxyanion hole”. The
proton is then transferred from the histidine to the leaving alcohol
group, while the acid group of the substrate becomes covalently
bound to the serine forming the covalent intermediate. Next, the histi-
dine activates a water molecule, which hydrolyzes the covalent inter-
mediate via nucleophilic attack on the carbonyl carbon of the
intermediate. After the hydrolysis, the histidine donates its proton
back to the serine, and the acyl component of the substrate is released
[11,15].
Although the catalytic machinery of α/β hydrolases is very similar,
themeans bywhich they bind substrates varies from protein to protein.
In most cases, the “cap” or “lid” domain, which shields the catalytic
triad, contributes to substrate binding [12]. This domain is usually
inserted at the C-terminal ends of strands β4,β6, β7, or β8, andmay dif-
fer considerably in size in the various enzymes [12].
Here, we report the crystal structure of NP at 1.75 Å resolution, with
a product analog in the active site, aswell as the crystal structure of CesB
at 2.0 Å resolution. Surprisingly, the NP and CesB structures resemble
more those of the C\C bond cleaving (MCP) hydrolases than the α/β
hydrolase fold esterases. Modeling of a substrate in the active site of
NP allowed to deﬁning the residues that determine their different
enantiopeciﬁcities, in agreementwith previous site-directedmutagene-
sis results [6].
2. Materials and methods
2.1. Expression, puriﬁcation, crystallization and structure determination
of NP
The nap gene coding for NP from B. subtilis Thai I-8 (CBS 679.85)was
cloned into B. subtilis I-85. Cells were grown in 2× YT medium and har-
vested by centrifugation. After treatment of the cells with lysozyme and
DNAse, the soluble fraction was harvested by centrifugation. Proteins
were precipitated with 60% ammonium sulfate and redissolved in
0.02 MMOPS buffer, pH 7.5, and ultraﬁltratedwith anAmicon YMﬁlter.The resulting solution was applied to an analytical HPLC-SEC column
(TSK 2000 SW, 2 times 300 × 7.5 mm), and the protein was eluted
with 0.01 M MES (2-(N-morpholino)ethane sulfonic acid), pH 5.6, and
0.1 M NaCl with a ﬂow rate of 1 ml/min. The puriﬁed enzyme was
lyophilized [16].
Crystallization of naproxen esterase was performed as described
earlier [17]. In short, hexagonal plate-like crystals were grown by
liquid–liquid diffusion by ﬁlling glass capillaries with 5–10 μl of 80%
(w/v) PEG 6000 in 0.1 M Tris–HCl, pH 8.0, and closing them on one
side. The equivalent amount of the protein solution (10 mg/ml) in
0.1 M Tris–HCl was added on top of the PEG column and then the cap-
illaries were closed. The temperature was gradually increased over a
four-week period from 4 °C to room temperature.
Crystals were mounted in a cryoloop and ﬂash-cooled, without
adding any cryoprotectant, prior to data collection. Data were collected
on the BW7B beamline of the EMBL outstation at DESY (Hamburg,
Germany) at 100 K. Intensity data were processed using DENZO and
SCALEPACK [18]. The crystal diffracted to 1.75 Å and belonged to the tri-
gonal space group P3221 (Table 1), with one monomer of 33.8 kDa in
the asymmetric unit (corresponding to a calculated VM of 2.1 Å3/Da
[19], and an estimated solvent content of 40%).
The crystal structure of NP was solved by molecular replacement
with PHASER [20], using a searchmodel composed of three homologous
proteins, which were suggested by the Fold and Function Assignment
System (FFAS) server [21]. The searchmodelwas composed of the struc-
tures of Pseudomonas putida esterase (PDB ID: 1ZOI) [22], the meta-
cleavage product hydrolase (CumD) from Pseudomonas ﬂuorescens
IP01 (PDB ID: 1IUN) [23], and the 2-hydroxy-6-oxo-6-phenylhexa-2,4-
dienoate hydrolase (BphD) from Rhodococcus sp. strain RHA1 (PDB ID:
1C4X) [24], superimposed on each other.
Several cycles of manual re-building with Coot [25], automatic
model building with ARP/wARP [26], and reﬁnement with REFMAC5
[27] were performed in order to improve and to expand the original
model of 125 amino acid residues distributed in 6 β-strands and 5 α-
helices. Subsequently, a strategy to avoid model bias was applied,
employing density modiﬁcation, solvent ﬂattening, statistical phase im-
provement, and automated model building performed in cycles using
RESOLVE [28]. The best partial model generated by RESOLVE contained
180 amino acid residues with additional interpretable electron density,
suitable for manual building. The model was completed by a few cycles
with ARP/wARP and was further reﬁned with REFMAC5 using TLS re-
ﬁnement [29]. Water molecules were automatically added by Coot,
and manually checked. A 2-(2-hydroxyethoxy)acetic acid molecule
was included at the last stage of reﬁnement in the proximity of the nu-
cleophile Ser130. The ﬁnal model consists of 283 amino acid residues
(9–293), 220 water molecules and one 2-(2-hydroxyethoxy)acetic
acid molecule and has a R factor of 22.4% and Rfree of 26.4% (Table 1).
The ﬁrst 8 and last 7 residues are not visible in the electron density
and therefore not included in the ﬁnal model. The stereochemical
Table 1
Data collection and reﬁnement statistics.
Values in parentheses are for the highest resolution shell.
Data collection NP CesB (YbfK)
Space group P3221 P2
Cell dimensions a, b, c (Å)
α, β, γ (°)
47.0, 47.0, 212.5
90.0, 90.0, 120.0
82.1, 44.0, 108.7
90.0, 91.9, 90.0
Resolution range (Å) 40.0–1.75 46.0–2.04
Number of measurements 134364 154210
Number of unique reﬂections 28534 47148
Rmerge
†(%) 5.7 (20.4) 13.3 (39.4)
Completeness (%) 99.4 (100.0) 92.8 (76.1)
Overall I/σ (I) 21.4 (5.4) 7.1 (2.9)
Reﬁnement
Rcryst/Rfree
¶(%) 22.7/26.7 20.4/25.0
Geometry
R.m.s. deviation bonds (Å) 0.008 0.008
R.m.s. deviation angles (°) 1.2 1.2
Contents of asymmetric unit
No. of protein atoms 2290 4500
No. ligand atoms 1 2-(2-hydroxyethoxy)acetic acid 4 sodium ions
No. water atoms 220 461
Av. main chain B-factor 33.9 17.6/20.0
Av. ligand B-factor 49.5 –
Av. Water B-factor 40.3 26.1
Ramachandran plot
Favored regions (%) 96.8 96.5
Outliers (%) 0.4 0.0
Molprobity
Clashscore/percentile 7.1/88th 5.2/97th
Molprobity score/percentile 1.58/89th 1.51/97th
PDB ID 4CCW 4CCY
† Rmerge = hkl i|Ii(hkl) − 〈I(hkl)〉| ÷ hkl i Ii(hkl).
¶ Rcryst = hkl| Fobs − Fcalc | ÷ hkl Fobs , where Fobs is the observed structure factor and
Fcalc is the calculated structure factor. Rfree is the same asRcryst, except that itwas calculated
using 5% of the data that were not included in any reﬁnement calculations.
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has phi/psi angles in the disallowed region of the Ramachandran plot.
This strained conformation is due to crystal contacts.
2.1.1. Modeling of the enzyme–substrate complex
Modeling of an enzyme–substrate complex was performed with the
program Coot. The general position of the tetrahedral intermediate was
modeled by superposing the catalytic triad of NPwith the catalytic triad
of carboxylesterase Est30 from Geobacillus stearothermophilus in com-
plex with a covalently bound tetrahedral reaction intermediate (propyl
actetate) (PDB ID: 1TQH) [31]. Est30 has 16% overall sequence identity
to NP (Table S1).
Atomic coordinates and structure factor amplitudes have been de-
posited with the RCSB Protein Data Bank with accession code 4CCW
for carboxylesterase NP.
2.2. Expression, puriﬁcation, crystallization and structure determination
of CesB
The CesB genewas ampliﬁed from the pMAybfkvector [7] using two
synthetic primers. The forward primer (5′-GGGAGGGGCATT CCATGG
TACAAGATTC-3′) contained an NcoI restriction site (in bold) and the
reverse primer (5′-CTTTTCATG AAGCTT TTCCTTACTATTTTATC-3′)
contained a HindIII restriction site (in bold). The resulting PCR product
and the pBAD/Myc-HisA vector were digested with NcoI and HindIII re-
striction enzymes, puriﬁed, and ligated using T4 DNA Ligase. The liga-
tion mixture was used to transform competent Escherichia coli TOP10
cells. To verify the presence of the insert, transformants were selected
from LB/Amp plates, and analyzed by colony PCR. Positive clones weregrownovernight on LB/Ampmediumand the plasmidDNAwas isolated
for sequence analysis.
The vector pBAD/Myc-His Awas used for the expression ofwild type
CesB. E. coli TOP10 cells containing the appropriate expression plasmid
were inoculated in 2× LB/Amp medium (5 ml) and grown overnight
at 37 °C. Next day the A600 was determined for the overnight cultures
and a sufﬁcient quantity of the culture was used to inoculate 2× LB/
Amp medium (1 L) to an initial A600 of 0.05. Cultures were grown at
37 °C till A600 ≥ 0.5, when the cultures were induced with arabinose
(0.02%, w/v) and the temperature was changed to 20 °C. After 16 h
cells were harvested and resuspended in 3 mL/g of wet cells in extrac-
tion buffer (10 mM Tris–HCl, pH 8, 1 mM EDTA). Cells were disrupted
by sonication, and extracts were clariﬁed by centrifugation (50 min,
40,000 g). Puriﬁcationwas performed by anion exchange chromatogra-
phy using 3 HitrapQ columns (1.6 × 2.5 cm) with 10 mM Tris–HCl,
pH 8.0, and 1 mM EDTA as Buffer A, and Buffer A containing 1.0 M
NaCl as Buffer B. Further puriﬁcation was achieved by phenylsepharose
HP chromatography with 10 mm phosphate buffer, pH 8.0, containing
0.5 M ammonium sulfate as Buffer A, and Buffer B containing 10 mm
phosphate buffer pH 8.0 [5]. In addition, gel ﬁltration using a Hiload
Superdex 200 column (GE Healthcare) was used to determine the olig-
omeric state of CesB in solution (monomer) and for buffer exchange
(50 mM Tris HCl, 10% (v/v) glycerol, pH 8.0).
CesB crystalswere obtained from sitting-drop experimentswith 20%
polyethylene glycol 3350 and 0.2 M sodium ﬂuoride in 100 mM Bis–
Tris propane buffer (pH 6.0–7.0) as precipitant, using drops of 0.1 μl of
protein solution (5.2 mg ml−1 in 20 mM Tris buffer, pH 7.5, 100 mM
NaCl) and 0.1 μl of reservoir solution set up by theMosquito crystalliza-
tion robot. Crystals grew in space group P2 (Table 1) with two
monomers of 35.0 kDa in the asymmetric unit (corresponding to a cal-
culated VM of 2.8 Å3/Da [19], and an estimated solvent content of 56%).
Before data collection, crystals were soaked for 15 s in a cryoprotec-
tant solution, consisting of reservoir solution supplemented with 15%
glycerol, directly followed by ﬂash cooling. X-ray data were collected
in house at 110 K with a MarDTB Goniostat System using Cu-Kα radia-
tion from a Bruker MicrostarH rotating-anode generator equipped
with HeliosMX mirrors. Intensity data were processed using iMosﬂm
[32] and scaled using SCALA from the CCP4 suite [27].
The structure of CesB was solved by molecular replacement with
PHASER [20] using the NP structure as a search model. The phases
were improved with the ARP/wARP [26] procedure combined with
manual model building with Coot [25]. TLS reﬁnement [29] was per-
formed with REFMAC5 [27] and resulted in a ﬁnal model comprising 2
protein molecules of 285 residues each in the asymmetric unit, 2 sodi-
um ions and 460 water molecules, with a ﬁnal R factor of 20.4% and
Rfree of 25.0% (Table 1). No electron density was visible for the ﬁrst 10
residues and the C-terminal residues of both molecules and these resi-
dueswere therefore not included in the ﬁnalmodel. The stereochemical
quality of the model was assessed with MolProbity [30]. The sodium
ions were assigned by the STAN server [33].
Atomic coordinates and structure factor amplitudes of
carboxylesterase CesB have been deposited with the RCSB Protein
Data Bank with accession code 4CCY.
3. Results and discussion
3.1. Overall structure
The structures of B. subtilis Thai I-8 carboxylesterase NP and
B. subtilis 168 CesB were solved by molecular replacement and reﬁned
to 1.75 Å resolution (space group P3221) and 2.04 Å resolution (space
group P2), respectively. Data collection and reﬁnement statistics are
summarized in Table 1. The asymmetric unit of the NP crystal contains
one proteinmolecule of 283 amino acid residueswhereas the asymmet-
ric unit of the CesB crystal contains two protein molecules of 285
residues each. Both carboxylesterases have a globular shape with
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structure with a root mean square deviation (RMSD) value of 0.94 Å
for 273 Cα pairs, as expected from their high sequence identity (64%).
Like most of the members of the α/β hydrolase fold family, the NP
and CesB structures consist of two domains: a central α/β “core” do-
main, containing the catalytic triad, and an α-helical “cap” region on
top of it, responsible for substrate recognition/binding (Fig. 2). It should
be noted that NP is 98.0% identical in sequence to B. subtilis strain 168
CesA, differing only in 6 amino acids (L101V, K181T, T188N, Q202K,
K217N, A282T) located on the surface of the protein and not inﬂuencing
the speciﬁc activity of the proteins [7]. Recently a putative hydrolase
(2632844) from B. subtilis strain 168 was deposited with the Protein
Data Bank (PDB ID: 2R11) (http://dx.doi.org/10.2210/pdb2r11/pdb)
as part of a structural genomics project (Joint Center for Structural
Genomics). This enzyme has 100% sequence identity to B. subtilis CesA.
As expected, the crystal structures of NP and CesA are very similar, hav-
ing a RMSD value of 0.55 Å over 282 Cα pairs. CesB is also highly similar
to these two enzymes, and therefore the structural description will
focus onNP. Speciﬁc differences among the structureswill be eventually
highlighted.
The NP core domain comprises residues 30–157 and 224–300, and it
consists of a central eight-stranded, predominantly parallel β-sheet
ﬂanked by one 310-helix (η2) and three α-helices on one side (α2,
α10 and α11) and by four α-helices (α3, α4, α8 and α9) and one
310-helix (η3) on the other side (Figs. 2a, S1 and S2). The core domain
has two 310-helices (η2 and η3), a small β-strand (β4′) and one small
α-helix (α10) extra compared to the ‘canonical’ α/β hydrolase fold
[9,10,12]. Additionally, in CesB a small antiparallel β-sheet is formed
with β6′and β6″ (Figs. 2b, S2). Furthermore, CesA misses η1 and η4
but has a small β-strand β6′.
The cap domain comprises the N-terminal residues 1–29 and resi-
dues 158–223 (inserted between strand β6 and helix α8) and consists
of four α-helices (α1, α5, α6 and α7) and one 310-helix (η4) (Figs. 2a,
S2). The η4 310-helix is located before helix α7 in NP, while it is after
α7 in CesB (Fig. 2B). In this class of esterases the most striking feature
of the cap domain is the presence of the N-terminal helix α1, which is
situated almost parallel to helix α7 and ends as a 310-helix (η1). Inter-
actions between α1 and α7 are mainly hydrophobic. An N-terminal
α-helical extension is rare for α/β hydrolase fold proteins, being ob-
served only in the hormone-sensitive lipase subfamily of enzymes
such as brefeldin A esterase from B. subtilis (PDB ID: 1JKM) [34], Est2
from Alicyclobacillus acidocaldarius (PDB ID: 1EVQ) [35,36], AFEST, aFig. 2. Structures of (A) NP from Bacillus subtilis Thai I-8, and (B) CesB from Bacillus subtilis 168
strands yellow/magenta, and the helices of the cap domains slate blue/salmon, respectively. Th
mark the amino and carboxylate termini of the proteins.novel hyper-thermophilic carboxylesterase from the archaeon
Archaeoglobus fulgidus (PDB ID: 1JJI) [37] and acetyl esterase HerE
from Rhodococcus sp. strain H1 (PDB ID: 1LZL) [38]. In these four en-
zymes the cap domain is built up of two N-terminal α-helices and two
α-helices from the insert located after strand β6. Kinetic data of Est2 in-
dicate that the ﬁrst 35 residues of the protein play a role in the confor-
mational stability of the protein and have a regulatory role [36,39]. It
is likely that the N-terminal α-helix in the carboxylesterases has a sim-
ilar function. ADALI search [40]with theα/β hydrolase core domain did
come up with many structural neighbors (Table S1). In contrast, for the
isolated cap domain no neighbors were found, which makes these
carboxylesterases unique in the family of esterases.
The cap domain is also the protein region where most of the se-
quence variations are present between NP and CesB (Fig. S1). The
most disparate part is at amino acids 209–218 where differences in
amino acid sequence have direct structural implications, such as the
presence of the 310-helix η4 (residues 210–212) in CesB but not in NP,
or the narrower active site entrance in CesB (Fig. 3). Variations in se-
quence are also observed in the active sites of NP and CesB [6],
explaining the different substrate speciﬁcities (see below).3.2. Sodium ion binding to CesB
Two sodium ions, originating from the crystallization solution, are
bound to each of the two CesB monomers present in the asymmetric
unit (Fig. 4). The ﬁrst sodium ion (Na1) (Fig. 4A) is bound in a pocket
lined by residues 244 to 250 (loop between strand β7 and helix α9). It
is octahedrally coordinated by Oε1 of Gln250 (2.34 Å), the carbonyl ox-
ygen atom of Glu245 (2.31 Å), the carbonyl oxygen atom of Tyr248
(2.69 Å), and three water molecules (2.59 Å, 2.53 Å, and 2.46 Å). Inter-
estingly, Glu245 is the acidmember of the catalytic triad. There is no so-
dium ion bound in NP or CesA at this position, where Gln250 is
substituted for a Pro. The other sodium ion (Na2) (Fig. 4B) is located
15 Å away from Na1; it also has an octahedral geometry, being coordi-
nated by Thr187Oγ1 (2.48 Å), the carbonyl oxygen atom of Gly188
(2.32 Å), the carbonyl oxygen atom of Tyr191 (2.45 Å), and three
watermolecules (2.33 Å, 2.44 Å, and 2.33 Å). The coordinating residues
are part of the loop connecting helices α6 andα7 of the cap domain. At
this location no sodium ion is bound in NP or CesA; the structures in this
region are themost divergent. Thebinding of sodium could be a result of
the puriﬁcation and crystallization procedures.. The proteins are shown as cartoons with helices of the core domains colored red/cyan, β-
e catalytic triads, S130, H274 and Glu245, for both esterases, are shown as sticks. N and C
Fig. 3. Entrances to the active sites of NP (A) and CesB (B). (C), structure of NP showing the absence of a back-access channel, blocked by Phe66, in blue and the residues with the largest
conformational differences between the carboxylesterases in red. (D), surface plot of NP showing one possible route to and from the active site.
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The active site of NP is located at the interface between the core and
the cap domains in a ~13 Å deep hydrophobic gorge. Its entrance is
lined by residues from helices α5, α6, and α7 and from a loop located
after helix α7, all belonging to the cap domain. The active site nucleo-
phile Ser130 is located at the bottom of the gorge, protected from the
bulk solvent, on the nucleophilic elbow between strand β5 and helix
α4 as part of the conserved sequence motif Gly–Leu–Ser–Leu–Gly.
The main chain conformation of this serine is somewhat strained
(φ = 53°, ψ = −125°), as more often observed in α/β hydrolases,
but still in the allowed region of the Ramachandran plot. Its conforma-
tion is stabilized by a network of hydrogen bonds of the Ser130 carbonyl
oxygen atom to the backbone amides of Gly132 (3.1 Å), Gly133 (2.9 Å),
and Ala156 (3.0 Å). The Ser130 backbone amide is at hydrogen bonding
distance to the carbonyl oxygen atoms of Leu153 (3.0 Å) and Ser154
(3.1 Å). Furthermore, in NP the Ser130 Oγmakes a hydrogen bond to
the backbone amide of Leu131, which induces an unfavorable confor-
mation of the nucleophile for the reaction to occur (Fig. 5A). On the con-
trary, in both CesBmonomers the Ser130 Oγ is hydrogen bonded to the
Nε2 atom of the catalytic His274 (2.8 Å) (Fig. 5B). This observation
suggests the presence of two populations existing for the Ser130 Oγ,
one making a hydrogen bond to the backbone amide of Leu131
(representing the so called “resting” state, with a χ1 of 153°), another
making a hydrogen bond to the His274 side chain (the “active” state,
with a χ1 of−159°). Indeed, the catalytic His274 in α/β hydrolases is
supposed to act as a base, deprotonating the serine to generate a very
nucleophilic alkoxide (\O−) group. Interestingly, in CesA, where four
independent molecules are present in the asymmetric unit, both popu-
lations are present, each associated with two monomers. The resting
state found in NP is also reminiscent of that observed for the active
site cysteine of dienelactone hydrolase [12]. Another example is givenFig. 4. Sodium ionsNa1 (A) andNa2 (B) binding to CesB. CesB is depicted as a cartoon in grey. Se
colored in green. Black dashed lines indicate interactions of the sodium ions with the amino acby B. subtilis lipase, although the resting state of the catalytic serine
has a different conformation with a χ1 of 52° [41]. These different con-
formations of the catalytic serine side chain support the notion that dif-
ferent orientations of its hydroxyl group are a necessary requirement for
the enzymatic activity [41].
Regarding the third member of the catalytic triad, Glu245 is hydro-
gen bonded to His274, orienting its imidazole ring such that it interacts
with Ser130. Having a glutamate residue as the thirdmember of the cat-
alytic triad is quite atypical; in otherα/βhydrolases and serine esterases
normally an aspartate residue is observed. A glutamate as member of
the catalytic triad has been found in the family of large esterases (LES,
with molecular weights above 55 kDa, subfamily VII [42]) like butyryl-
cholinesterases, acetylcholinesterases, human carboxylesterase and
fungal lipases. Also Est713 [43], a smaller esterase of 35.5 kDa has a glu-
tamate as the third catalytic residue but it is positioned at the end of β6,
whereas in the carboxylesterases the glutamate is located at the end of
β7, the usual position for the catalytic acid residue in theα/β hydrolase
fold enzymes.
Finally, in NP the amide NH groups of Ala64 (Gly64 in CesB) and
Leu131 form the oxyanion-binding site that stabilizes the tetrahedral
transition-state intermediates (Scheme 1).
3.4. Product in the active site of carboxylesterase NP
An unexpected residual electron density was observed in the active
site of NP, near the side chain of Ser130 (Fig. 5A). This electron density is
probably indicative of binding (part of) a chain of acidiﬁed PEG from the
crystallization solution. The crystal was grown from 40% PEG and was
stored for several years in this solution before data were collected. It is
known that polyethylene glycol solutions get oxidized by air after
prolonged storage [44]. We modeled it as 2-(2-hydroxyethoxy)acetic
acid. One of the carboxylate oxygen atoms is weakly hydrogen bondedlected amino acids are shown as sticks colored according to atom type. The catalytic triad is
ids and water molecules.
Fig. 5. View of the active sites, catalytic triads and oxyanion-binding sites of NP (A) and CesB (B). Selected amino acids are shown as sticks colored according to atom type. Amino acids in
CesB that differ from the equivalent ones inNP are colored in salmon. The aminoacids of the catalytic triad are colored in green. Themain chain atoms of Leu131 andAla/Gly64 are included
to mark the oxyanion-binding site. The product, 2-(2-hydroxyethoxy)acetic acid, is colored in cyan. The omit map is shown as a grey mesh and contoured at 1σ.
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(3.4 Å). The other carboxylate oxygen is hydrogen bonded to the car-
bonyl group of Ala64 (2.9 Å), of which residue the amide nitrogen
atom is involved in the oxyanion binding site (Fig. 5), but no interac-
tions are present between the product analog and the oxyanion binding
site amides. Several van der Waals interactions are present instead be-
tween the bound molecule and Ala64, Leu65, Phe166, Ala170 and
Phe182 at the entrance of the active site.
In CesB only water molecules were found in the active site, but in
CesA an ethyleneglycol molecule and a triethyleneglycol molecule
were modeled in two of the four monomers in the asymmetric unit.
The ethyleneglycol molecule in monomer B (active state) resides
in about the same location as the product analog in NP; theScheme 1. Proposed mechanism of esterase-catalyzed hydrolysis of naproxen me
The ﬁgure has been adapted from Jaeger et al. [15].triethyleneglycol molecule in monomer C (resting state) is also located
at the entrance to the active site but bound via van der Waals interac-
tions to Leu131 and Pro222. This shows the wide-open entrance to
the active site of these carboxylesterases.
3.5. Structural differences in the NP and CesB active sites and
enantioselectivity properties
While (R,S)-ethoxyethyl-[2-(6-methoxy-2-naphtyl)]propionate is
enantioselectively hydrolyzed by NP to yield optically active (S)-
naproxen, the enzyme hydrolyzes IPG-esters without enantioselectivity
[7]. This lack of enantioselectivity towards IPG-substrates is mainly due
to two residues, Phe166 and Phe182, in the active site as demonstratedthyl ester. The chiral carbon in the substrate is marked with an * (asterisk).
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[6]. In contrast, CesB hydrolyzes 1,2-O-isopropylideneglycerol esters to
(S)-IPGwith 99.9% enantioselectivity. Thus both esterases are highly se-
lective, but NP is enantioselective towards the acyl/aryl part of sub-
strates, while CesB speciﬁcally recognizes the chirality of the alcohol
part, with some additional enantioselectivity towards the acyl/aryl part.
Since NP (and its homolog CesA) have a high enantiospeciﬁcity
for S-naproxenethylester (99%) [7], we tried to model the S- and R-
naproxenester substrates in the active site of NP (Fig. 6). For themodel-
ing, several interactions were taken into account. For productive
binding, the substrate's ester carbonyl oxygen atom needs to make hy-
drogen bonds to the two NH-groups of the oxyanion hole (Ala64 in NP,
Gly64 in CesA, and Leu131 in both). Furthermore, the Nε2 atom of the
catalytic His274 should be at hydrogen bonding distance to the oxygen
of the substrate alcohol and to the catalytic Ser130 Oγ. In this conﬁgu-
ration the substrate S-naproxenethylester binds with the alcohol moie-
ty deep in the active site, and the naphtyl group at the hydrophobic
entrance to the active site. Note, that the entrance to the active site is
only 5.7 Å wide, measured between Cβ of Ala64 and Cζ of Phe166,
and that it functions as a slit pocket. Using the same requirements, the
model did not yield a productively bound R-naproxen ester substrate
because of steric hindrance of the R-naproxen methyl group by
Ala165, in agreement with the lack of activity of the enzyme towards
this compound [7].
Applying the same criteria for productive binding, as used to model
the naproxen ester in the active site of NP, the IPGmoiety of the IPG es-
ters most likely binds in the alcohol-binding pocket. The size of this
pocket is mainly limited by Phe66 (Fig. 6), and could ﬁt only methyl
or ethyl substrates, in agreement with the enzyme's activity on
naproxen methyl and ethyl esters [7]. However, the ability of the
carboxylesterases to also hydrolyze the larger IPG esters [5,7] suggests
that the active site alcohol-binding pocket is sufﬁciently ﬂexible to ac-
commodate the IPG-moiety. Only if Phe66, located at the interface be-
tween the two domains (Fig. 6A), adopts a different conformation, the
alcohol-binding pocketwould be able to accommodate the larger IPG al-
cohol moiety. Similar conformational changes have been observed in
B. subtilis lipase [45,46] where, upon binding of an IPG-like inhibitor,
the alcohol-binding pocket expanded to accommodate the IPG moiety
of the inhibitor.
CesB is enantioselective towards IPG caprylate ester [6], but NP is
not. Indeed, our model shows that in CesB Tyr182 interacts with one
of the IPG ring oxygen atoms, thus favoring the binding of the (S) enan-
tiomer over the (R) enantiomer of IPG, where this hydrogen bond is not
possible. In contrast, in NP the residue equivalent to Tyr182 is a Phe,
which cannot make this hydrogen bonding interaction, resulting in a
less selective binding.
It is noteworthy that in the carboxylesterases NP, CesB and CesA no
separate entry and exit routes (backdoor, side-door, or tunnel) forFig. 6. Stereo image of themodeling of the tetrahedral intermediate of (S)- (in cyan) and (R)-na
access to the active site, are colored in yellow.substrate and product are observed. The exit route found in other ester-
ases [47] is blocked by Phe162, His163, Pro164, Asp165 and Val166, all
from the cap domain. Likewise, a possible water tunnel at the end of
the alcohol-binding pocket is blocked by Phe66 (Fig. 3c,d). As a conse-
quence, only one possible route to and from the active site is present
in NP and CesB. However, in the reaction pathway the alcohol product
is supposed to be the ﬁrst to leave the active site (Scheme 1), but the
exit route is blocked by the covalently bound acid part of the substrate.
Similarly, the entrance route for the hydrolytic water molecule is
obstructed. Yet, a lid-like movement of the cap domain (in particular
of the ﬂap made by helices α5 and α6) may be sufﬁcient to allow the
water molecule to enter the active site, and the products to be released.
Indeed, the mainly hydrophobic interactions of the residues of helices
α5 and α6 with the core domain could facilitate such a lid-like move-
ment. Similar mechanisms of active site opening through cap domain
helix relocation occur in family I.1 lipases [48,49] as well as in other
α/β hydrolases [50,51].3.6. Comparison to other α/β hydrolase fold esterases; similarity with
meta-cleavage product hydrolases
A search of the Dali database [40] revealed that the NP and CesB
structures are not very similar to those of other esterases, with the ex-
ception of the meta-cleavage product (MCP) hydrolases (Table S1). In
general, the active site residues and oxyanion binding site amides are
structurally conserved, but the alcohol-binding pockets of CesB and
NP are smaller than those of other esterases with known structure.
In NP the acyl part of the substrate likely binds in the entrance to the
active site as shown in Fig. 6. In contrast, in otherα/β hydrolase fold es-
terases the acyl part is usually bound in a deep hydrophobic pocket at
the interface between the two domains [31,51,52]. However, at that po-
sition in NP, Ala156 and Glu157, two residues located at the domain in-
terface, prevent binding of substrates containing a large acyl moiety.
Instead, the acyl moiety binds in the entrance to the active site. This is
possible, because the helices in the cap domain have a different position,
causing the active site entrance of NP and CesB to have a different loca-
tion compared to other esterases.
A secondary structure motif (SSM) search [53] of the PDB indicated
signiﬁcant structural similarity of the carboxylesterases NP and CesB
with C\C bond breaking enzymes that belong to the MCP hydrolase
family [54]. These latter enzymes have 19–20% sequence identity to NP
(Table S1) and overall root mean square (r.m.s.) deviations of less than
2.3 Å. This superfamily of cytosolic hydrolases also includes soluble
non-heme peroxidases, epoxide hydrolases, ﬂuoroacetate dehalogenases
and haloalkane dehalogenases [55]. Several MCP hydrolase family
members also show esterase activity [56]. Intriguingly, compared to
the dual speciﬁcity ester/MCP hydrolases, CesB and NP have an Ala156proxen ester (inmagenta) in the active site of NP. Amino acids Phe66 and A156, restricting
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active site, which probably contributes to their enantioselectivity.
Carboxylesterases and MCP hydrolases share a common position of
the cap domain. In someMCP hydrolases theα-helical lid (correspond-
ing to residues 199–213 of CesB/NP) closes upon ligand binding [57] re-
ducing the solvent accessibility of several hydrophobic residues. In NP
and CesB residues 214–227, in the loop after helix α7, show the largest
conformational differences compared to theMCP hydrolases (Fig. 3c). In
fact, this is also the regionwhere the structures of NP, CesA and CesB are
most different. From these observations we conclude that the residues
in this regionmay be ﬂexible,which is also apparent from their elevated
B-factor values. We suggest that this ﬂexibility may be important to
accommodate different substrates.
4. Conclusions
The structures of the B. subtilis carboxylesterases NP and CesB deter-
mined in the present study are very similar. Comparison of these struc-
tures to those of other α/β hydrolase fold esterases revealed that the
main difference is the location of the entrance to active site, mainly be-
cause of a different positioning of the cap domain. In this respect NP
and CesB resemble much more the MCP hydrolases, halogenases,
dehalogenases and epoxide hydrolases than other esterases. Modeling
of a substrate in the active site of NP indicates that the acyl chain is
most likely bound at the entrance to the active site, unlike most other
esterases, which have a well-deﬁned pocket at the interface between
the core and the cap domains.
Enantioselectivity of the carboxylesterases towards the IPG-
substrates is mainly due to a few residues in the active site, Phe166
and Phe182 in NP vs Val166 and Tyr182 in CesB. Ala156, an insertion
in the carboxylesterases, may be a determinant of enantioselectivity as
well, since its side chain appears to interfere with the binding of certain
enantiomers in the active site ofNP as shown by the substratemodeling.
In NP and CesB a lid domain movement for binding of the substrate
and release of the product seems possible by movement of the ﬂap
made by helices α5 and α6 or/and of the loop after helix α7, where
most of the amino acid and conformational differences between the
three esterases occur. Such movements could also explain their activity
on alcohol groups of the substrates that are too large to bind in the pres-
ent conformation of the carboxylesterases.
Altogether, these observations make the carboxylesterases
unique members of the esterase family, with their own speciﬁc
enantiospeciﬁcities, and indicate an evolutionary relationship to
the soluble meta-cleavage compound hydrolases.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbapap.2014.01.003.
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